Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nurix Therapeutics Inc (NQ: NRIX ) 21.94 +0.90 (+4.28%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nurix Therapeutics Inc < Previous 1 2 3 Next > Analyst Scoreboard: 12 Ratings For Nurix Therapeutics July 15, 2024 Via Benzinga Here Is What You Missed On Wall Street On Friday July 14, 2024 Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. Via Talk Markets Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts June 27, 2024 Via Benzinga Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance June 21, 2024 The Nasdaq and S&P 500 backed off highs. The Dow regained a key level. Via Investor's Business Daily Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday June 18, 2024 Via Benzinga Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights June 05, 2024 Via Benzinga Key Takeaways From Nurix Therapeutics Analyst Ratings May 14, 2024 Via Benzinga Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know April 02, 2024 Via Benzinga What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? June 17, 2024 Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for... Via Benzinga Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket June 17, 2024 Via Benzinga Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial June 17, 2024 San Francisco-based Nurix Therapeutics reported robust results in an ongoing treatment against a stubborn form of leukemia. Via Investor's Business Daily Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 17, 2024 We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning! Via InvestorPlace Analyst Scoreboard: 7 Ratings For Nurix Therapeutics March 11, 2024 Via Benzinga Decoding 4 Analyst Evaluations For Nurix Therapeutics February 16, 2024 Via Benzinga The Latest Analyst Ratings for Nurix Therapeutics October 13, 2023 Via Benzinga Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 12, 2024 Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Via Benzinga Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session April 12, 2024 U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket April 12, 2024 Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year Via Benzinga What 4 Analyst Ratings Have To Say About Nurix Therapeutics September 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session April 11, 2024 Via Benzinga Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Via Benzinga Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday April 11, 2024 U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. Via Benzinga Topics Stocks Exposures US Equities NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024 April 10, 2024 NRIX stock results show that Nurix Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session April 09, 2024 Via Benzinga BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday April 09, 2024 U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. Via Benzinga Topics Stocks Exposures US Equities Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session December 28, 2023 U.S. stock futures were mixed this morning, with the Dow Jones futures falling around 40 points on Thursday. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Topics Stocks Exposures US Equities Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors December 13, 2023 From Toll Brothers, Inc. Via GlobeNewswire 10 Health Care Stocks With Whale Alerts In Today's Session December 11, 2023 Via Benzinga Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On? October 17, 2023 Via Benzinga Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today? September 07, 2023 Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.